Does the homologous booster with the inactivated coronavirus disease 2019 vaccine work for the omicron variant? Real-world evidence from Jilin, China.

Author: Jun GUO ¹ ; Lei ZHA ² ; Kai ZENG ³ ; Mingyu SHAO ⁴ ; Dan CHEN ⁵ ; Bing WANG ⁶ ; Yun ZHOU ⁷ ; Gang YANG ⁷ ; Xue ZHANG ¹ ; Xia ZOU ⁸ ; Yan ZHANG ¹ ; Yan KANG ¹
Author Information

1. Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China.
2. Intensive Care Unit, Conch Hospital of Anhui Medical University, Wuhu, Anhui 241000, China.
3. Critical Care Unit, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150000, China.
4. Hospital Administration Office, Jilin Central General Hospital, Jilin, Jilin 132000, China.
5. Medical Administration Department, Jilin Central General Hospital, Jilin, Jilin 132000, China.
6. Department of Cardiology, Jilin Central General Hospital, Jilin, Jilin 132000, China.
7. Department of Pulmonary and Critical Care, Wuhu Hospital, East China Normal University, Wuhu, Anhui 241000, China.
8. Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China.
Publication Type:Journal Article
MeSH: Humans; COVID-19 Vaccines/therapeutic use*; COVID-19/prevention & control*; SARS-CoV-2; China; Antibodies, Viral
From: Chinese Medical Journal 2023;136(23):2892-2894
CountryChina
Language:English